Vitamin D
Most people supplementing vitamin D are taking too much, dosing it wrong, and missing the cofactors that make it work
Conviction: HIGHTonight, check your vitamin D bottle. If it says anything above 2,000 IU, or if you take it weekly/monthly instead of daily, switch to 1,000-2,000 IU daily with a magnesium supplement. That single change is worth more than chasing a blood level.
Think of vitamin D like watering a garden. A gentle daily sprinkle keeps everything growing steadily. But if you dump a whole week's water at once, most of it floods past the roots and the soil actually becomes harder to absorb through. Your body works the same way — a big monthly dose triggers a shutdown enzyme that blocks your cells from using the vitamin D you just took. Small and steady wins.
Most people supplementing vitamin D are taking too much, dosing it wrong, and missing the cofactors that make it work
Conviction: HIGHTonight, check your vitamin D bottle. If it says anything above 2,000 IU (one standard capsule), or if you take it weekly or monthly instead of daily, switch to 1,000-2,000 IU daily and add a magnesium supplement.
Daily dosing preserves a 12% cancer mortality reduction and 19% fewer respiratory infections. Bolus dosing wipes out both benefits by triggering a shutdown enzyme in your cells.
Takes 30 seconds. Just read the label.
The Verdict
A small daily dose of vitamin D beats a large weekly one, and most people are chasing blood levels that do not matter.
Think of vitamin D like watering a garden. A gentle daily sprinkle keeps everything growing steadily. But if you dump a whole week's water at once, most of it floods past the roots and the soil actually becomes harder to absorb through. Your body works the same way — a big monthly dose triggers a shutdown enzyme that blocks your immune cells from using the vitamin D you just took. Small and steady wins.
Want the full evidence? Keep scrolling
What Most People Think
Walk into any health-conscious person's supplement shelf and you will almost certainly find a bottle of vitamin D — usually 5,000 IU, sometimes 10,000. The longevity space has turned vitamin D into a status signal: higher blood levels mean you are more "optimized."
The standard story goes like this: most people are deficient, labs set the bar too low at 20, the real sweet spot is 50-80, and you need serious doses to get there. Some influencers recommend monthly mega-doses of 50,000-60,000 IU for convenience.
The evidence tells a very different story. And the dosing pattern most people use may be actively working against them.
What the Evidence Actually Shows
The 2024 Endocrine Society Clinical Practice Guideline — the most authoritative body in this space — formally abandoned the 30 target for healthy adults. This was not a minor tweak. They reviewed every large randomized trial and concluded: raising levels above 20 produces no measurable benefit for cancer, heart disease, or fractures in people who are not severely deficient.
Here is what that means in plain terms: if your blood test comes back at 25 and your doctor says "a bit low," the latest evidence says you are fine. The labs flagging anything under 30 as deficient are using an outdated threshold.
This is the single most important finding in the vitamin D field, and almost nobody knows about it.
The largest analysis isolating dosing frequency (Guo et al., 2022 — 14 trials, 104,727 people) found that daily vitamin D supplementation significantly reduced cancer mortality by about 12%. But monthly bolus dosing showed a risk ratio of 1.05 — trending toward harm.
The D-HEALTH trial (21,315 people, 60,000 IU per month for 5 years) found a 24% increase in cancer mortality in exploratory analysis. The very pattern many health-conscious people use — big infrequent doses — may be doing the opposite of what they intend.
An individual participant data analysis (Martineau et al., 2017 — over 10,933 people) found that daily or weekly vitamin D reduced respiratory infections by 19%, with a number needed to treat of 20. That means for every 20 people taking daily vitamin D, one infection is prevented.
Monthly bolus dosing? Flat. No benefit at all. The mechanism is now understood: a large spike in blood levels triggers an enzyme called CYP24A1 that breaks down the active form of vitamin D. Your immune cells literally cannot use the vitamin D you just took because the spike told your body to shut down the activation pathway.
The RECORD trial gave 5,292 elderly adults 800 IU of D3 plus 1,000 mg of calcium versus placebo. The fracture rates were virtually identical — hazard ratios between 0.94 and 1.02, all non-significant. Long-term follow-up showed zero difference in mortality either.
Vitamin D corrects severe deficiency-induced bone loss. That is a real and important effect. But it does not prevent the kind of age-related fractures most people worry about. If you are taking vitamin D specifically for bone health, you need the full cofactor stack — not just the vitamin D alone.
A trial of 250 people found that combining magnesium (360 mg per day) with vitamin D raised blood levels 6.3 points more than vitamin D alone. Every single step of turning vitamin D into its active form — in your liver, in your kidneys, at the cellular level — requires magnesium. Without it, high-dose D3 actually depletes your magnesium stores.
Vitamin K2 (specifically the MK-7 form) solves the calcium problem. Vitamin D increases how much calcium your gut absorbs. K2 tells that calcium where to go — into bone, not into artery walls. The AVADEC trial (389 people) found that K2 combined with D3 reduced cardiovascular events from 6.7% to 1.9% in a high-risk group. That is a 3.5 times difference.
The Debate
Observational data + many clinicians
Hundreds of observational studies link higher vitamin D levels (40-60) with lower rates of cancer, cardiovascular disease, and all-cause mortality. Many doctors argue the Endocrine Society is being too conservative and that 30-50 should remain the target.
Randomized controlled trials + 2024 Endocrine Society guideline
When you actually correct low levels with supplements in large randomized trials (VITAL: 25,871 people; D-HEALTH: 21,315 people), the disease benefits largely disappear. The observational link is confounded — sick, sedentary, overweight people have low vitamin D because they do not go outside, not because low D caused their illness.
The trial evidence currently supports the 20 floor. Observational data, no matter how large, cannot overcome the confounding problem. Until a large trial shows that daily dosing to 40-60 beats daily dosing to 20-30 on hard outcomes, the higher targets remain aspirational, not evidence-based.
Honest Limitations
The Practical Takeaway
The Nuance
Reference ranges in many labs were set based on observational data linking low vitamin D to chronic disease. But that relationship is confounded by reverse causality. Sick, sedentary people do not go outside, so their vitamin D is low. The low vitamin D is a marker of being unwell, not the cause. Correcting the number with a pill does not fix the underlying disease.
The labs that flag anything under 30 as "deficient" are using a threshold the current Endocrine Society guidelines have formally abandoned. If you have been told you are "insufficient" at 25, the most authoritative body in the field now says you are fine.
This is not a case of "less efficient." It is the opposite direction. When you take a large bolus dose, the spike in blood levels triggers an enzyme (think of it as a shutdown switch) that creates a refractory period lasting weeks. During this window, your immune cells cannot locally activate vitamin D — the very pathway that produces the infection-fighting and cancer-protective effects.
You can have a blood level of 50 and still have functional immune resistance to vitamin D because of a single monthly 60,000 IU dose. The blood number looks great. The cellular reality is the opposite.
Everything above applies to people with levels above 20 chasing 50-80 targets. For individuals with genuine severe deficiency — below 12 — the benefits of supplementation are substantial across immune function, bone health, and mental health. Correcting true deficiency is a completely different clinical question from optimizing for longevity. If your levels are that low, work with your doctor on a correction protocol.
The 12% cancer mortality reduction from daily D3 was restricted to normal-weight individuals in the Guo meta-analysis. Overweight and obese individuals experienced no significant benefit — likely because vitamin D gets trapped in fat tissue (a process called volumetric dilution). If you carry significant body fat, higher daily doses (2,000 IU) may be needed just to maintain replete levels, without necessarily expecting the mortality signal.
Sources
Want help building a supplement stack that actually matches the evidence? Work with SLH Fit
Produced by SLH Fit Coaching · Truth Engine · Not medical advice.
How strong is the evidence for the claims in this review? Higher = more confidence the claims are supported. This does not measure how large the effect is or how important it is compared with other levers.
Is this worth your time, money, effort, risk, and trust for this goal? Different from Verdict Score (evidence strength) and Leverage Map (relative importance) — Action ROI is the worth-it call once friction is priced in.
Evidence-scored dosing, timing, forms, and who should skip it. One page, no fluff.
Get the protocolConviction-scored verdicts on supplements, nutrition, training, physio, and recovery.